HNF1B nephropathy has a slow-progressive phenotype in childhood-with the exception of very early onset cases: results of the German Multicenter HNF1B Childhood Registry
Language English Country Germany Media print-electronic
Document type Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't
PubMed
30666461
DOI
10.1007/s00467-018-4188-8
PII: 10.1007/s00467-018-4188-8
Knihovny.cz E-resources
- Keywords
- Cystic kidney disease, GFR decline, HNF1B, Hypomagnesemia, MODY,
- MeSH
- Kidney Failure, Chronic genetics MeSH
- Child MeSH
- Phenotype MeSH
- Genetic Association Studies MeSH
- Hepatocyte Nuclear Factor 1-beta genetics MeSH
- Infant MeSH
- Humans MeSH
- Adolescent MeSH
- Infant, Newborn MeSH
- Polycystic Kidney Diseases genetics pathology physiopathology MeSH
- Child, Preschool MeSH
- Disease Progression MeSH
- Registries MeSH
- Age of Onset MeSH
- Check Tag
- Child MeSH
- Infant MeSH
- Humans MeSH
- Adolescent MeSH
- Male MeSH
- Infant, Newborn MeSH
- Child, Preschool MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Multicenter Study MeSH
- Research Support, Non-U.S. Gov't MeSH
- Geographicals
- Germany MeSH
- Names of Substances
- Hepatocyte Nuclear Factor 1-beta MeSH
- HNF1B protein, human MeSH Browser
BACKGROUND: HNF1B gene mutations are an important cause of bilateral (cystic) dysplasia in children, complicated by chronic renal insufficiency. The clinical variability, the absence of genotype-phenotype correlations, and limited long-term data render counseling of affected families difficult. METHODS: Longitudinal data of 62 children probands with genetically proven HNF1B nephropathy was obtained in a multicenter approach. Genetic family cascade screening was performed in 30/62 cases. RESULTS: Eighty-seven percent of patients had bilateral dysplasia, 74% visible bilateral, and 16% unilateral renal cysts at the end of observation. Cyst development was non-progressive in 72% with a mean glomerular filtration rate (GFR) loss of - 0.33 ml/min/1.73m2 per year (± 8.9). In patients with an increase in cyst number, the annual GFR reduction was - 2.8 ml/min/1.73m2 (± 13.2), in the total cohort - 1.0 ml/min/1.73m2 (±10.3). A subset of HNF1B patients differs from this group and develops end stage renal disease (ESRD) at very early ages < 2 years. Hyperuricemia (37%) was a frequent finding at young age (median 1 year), whereas hypomagnesemia (24%), elevated liver enzymes (21%), and hyperglycemia (8%) showed an increased incidence in the teenaged child. Genetic analysis revealed no genotype-phenotype correlations but a significant parent-of-origin effect with a preponderance of 81% of maternal inheritance in dominant cases. CONCLUSIONS: In most children, HNF1B nephropathy has a non-progressive course of cyst development and a slow-progressive course of kidney function. A subgroup of patients developed ESRD at very young age < 2 years requiring special medical attention. The parent-of-origin effect suggests an influence of epigenetic modifiers in HNF1B disease.
Bergmann Laboratory University Medical Center Freiburg Freiburg Germany
Children's Hospital Augsburg Augsburg Germany
Children's Hospital St Elisabeth and St Barbara Halle Germany
Cologne Center for Genomics University of Cologne Cologne Germany
Department of Pediatrics University of Zielona Góra Zielona Góra Poland
Institute of Human Genetics RWTH University Hospital Aachen Aachen Germany
Institute of Human Genetics University Hospital of Cologne Cologne Germany
Pediatric Nephrology Pediatrics 2 University of Duisburg Essen Essen Germany
Pediatric Nephrology University Campus Virchow University Children's Hospital Berlin Berlin Germany
Pediatric Nephrology University Children's Hospital Cologne Cologne Germany
Pediatric Nephrology University Children's Hospital Hamburg Hamburg Germany
Pediatric Nephrology University Children's Hospital Heidelberg Heidelberg Germany
Pediatric Nephrology University Children's Hospital Marburg Baldingerstrasse 1 35033 Marburg Germany
Pediatric Nephrology University Children's Hospital Münster Münster Germany
Pediatric Nephrology University Children's Hospital Prague Prague Czech Republic
Pediatric Nephrology University Children's Hospital Rostock Rostock Germany
See more in PubMed
Kidney Int. 2007 Mar;71(6):574-81 PubMed
J Am Soc Nephrol. 2017 Nov;28(11):3205-3217 PubMed
Hum Mol Genet. 1999 Oct;8(11):2001-8 PubMed
Nephrol Dial Transplant. 2004 Nov;19(11):2703-8 PubMed
Pediatr Nephrol. 2010 Feb;25(2):231-40 PubMed
Pediatr Nephrol. 2015 Jan;30(1):15-30 PubMed
Am J Obstet Gynecol. 2010 Oct;203(4):364.e1-5 PubMed
J Am Soc Nephrol. 2009 May;20(5):1123-31 PubMed
Clin J Am Soc Nephrol. 2011 Oct;6(10):2429-38 PubMed
Pediatr Clin North Am. 1987 Jun;34(3):571-90 PubMed
Kidney Int. 2011 Oct;80(7):768-76 PubMed
J Am Soc Nephrol. 2007 Mar;18(3):923-33 PubMed
Diabetes Care. 2018 Jan;41(1):e7 PubMed
Kidney Int. 2004 Aug;66(2):571-9 PubMed
Nucleic Acids Res. 2002 Jun 15;30(12):e57 PubMed
J Clin Pathol. 1971 Feb;24(1):57-71 PubMed
BMC Med. 2017 Dec 6;15(1):213 PubMed
Kidney Int. 2015 Oct;88(4):676-83 PubMed
Clin J Am Soc Nephrol. 2010 Jun;5(6):1079-90 PubMed
Nephrol Dial Transplant. 2013 Mar;28(3):550-66 PubMed
Oncotarget. 2017 Feb 28;8(9):14525-14536 PubMed
Nephron Clin Pract. 2010;115 Suppl 1:c279-88 PubMed
Diabetes Care. 2017 Nov;40(11):1436-1443 PubMed
J Clin Endocrinol Metab. 2009 Jul;94(7):2658-64 PubMed
J Am Soc Nephrol. 2017 Aug;28(8):2540-2552 PubMed
Am J Nephrol. 2015;42(1):85-90 PubMed
J Clin Chem Clin Biochem. 1982 Apr;20(4):235-42 PubMed
Fetal Pediatr Pathol. 2006 Mar-Apr;25(2):73-86 PubMed
J Med Genet. 2006 Jan;43(1):84-90 PubMed
Nat Genet. 1997 Dec;17(4):384-5 PubMed
J Clin Endocrinol Metab. 2002 Aug;87(8):3859-63 PubMed
J Am Soc Nephrol. 2006 Oct;17(10):2864-70 PubMed
Kidney Int. 2014 Nov;86(5):1007-15 PubMed
Kidney Int. 2016 Jul;90(1):203-11 PubMed
J Am Soc Nephrol. 2006 Feb;17(2):497-503 PubMed
J Am Soc Nephrol. 2011 Nov;22(11):2047-56 PubMed
Pediatr Transplant. 2016 May;20(3):467-71 PubMed
Kidney Int. 2002 Apr;61(4):1243-51 PubMed
Nat Rev Nephrol. 2015 Dec;11(12):720-31 PubMed
Diabetologia. 2017 Apr;60(4):625-635 PubMed
Am J Hum Genet. 2010 Nov 12;87(5):618-30 PubMed
Diabetes Care. 2018 Jan;41(1):e8-e9 PubMed
Diabetologia. 2001 Mar;44(3):387-8 PubMed
Mech Dev. 1999 Dec;89(1-2):211-3 PubMed
BMC Endocr Disord. 2016 Sep 13;16(1):50 PubMed
Diabetes Metab. 2017 Feb;43(1):89-92 PubMed
Mech Dev. 1991 Dec;36(1-2):47-58 PubMed
Biochem Biophys Res Commun. 2011 Jan 7;404(1):284-90 PubMed
Autosomal dominant tubulointerstitial kidney disease: A review
Autosomal dominant tubulointerstitial kidney disease: more than just HNF1β
Analysis of expression, epigenetic, and genetic changes of HNF1B in 130 kidney tumours